NovoSeven for non-hemophilia hemostasis.
D000925:Anticoagulants / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D005167:Factor VII / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D015942:Factor VIIa; D005252:Fees, Pharmaceutical; D006467:Hemophilia A / Q000097:blood* / Q000188:drug therapy; D006470:Hemorrhage / Q000097:blood / Q000188:drug therapy; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D019106:Postoperative Hemorrhage / Q000097:blood; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*
D000925:Anticoagulants; D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa